Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Ana Gómez-Rueda

1PUBLICATIONS

15CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Oct 15, 2020

Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors.

Iván Márquez-Rodas, Federico Longo, Maria E Rodriguez-Ruiz

Pageof 1

Frequent Collaborators

1 joint publications

Iván Márquez-Rodas

1 joint publications

Federico Longo

1 joint publications

Maria E Rodriguez-Ruiz

1 joint publications

Antonio Calles

1 joint publications

Santiago Ponce

1 joint publications

Belén Rubio-Viqueira

1 joint publications

Sara López-Tarruella

1 joint publications

Mariano Ponz-Sarvise

1 joint publications

Enrique de Miguel

1 joint publications

Rocío Ramos-Medina

Frequent Collaborators

1 joint publications

Iván Márquez-Rodas

1 joint publications

Federico Longo

1 joint publications

Maria E Rodriguez-Ruiz

1 joint publications

Antonio Calles

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

See more related videos

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

See more related videos